Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis
Trimethylamine N-oxide (TMAO) is a biologically active molecule generated by the gut microbiota. Accumulating evidences have indicated a close association between high plasma TMAO levels and the risk of developing atherosclerosis (AS). AS is considered a chronic inflammatory disease initiated by vas...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/4634172 |
id |
doaj-2827b9a49e0346509bce35ba02e95679 |
---|---|
record_format |
Article |
spelling |
doaj-2827b9a49e0346509bce35ba02e956792020-11-25T02:53:45ZengHindawi LimitedMediators of Inflammation0962-93511466-18612020-01-01202010.1155/2020/46341724634172Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into AtherosclerosisYarong Liu0Min Dai1School of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui, ChinaSchool of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui, ChinaTrimethylamine N-oxide (TMAO) is a biologically active molecule generated by the gut microbiota. Accumulating evidences have indicated a close association between high plasma TMAO levels and the risk of developing atherosclerosis (AS). AS is considered a chronic inflammatory disease initiated by vascular endothelial inflammatory injury. Both observational and experimental studies suggest that TMAO can cause endothelial inflammatory injury. However, a clear mechanistic link between TMAO and vascular inflammation of AS is not yet summarized. In this review, we discuss the association between TMAO and AS and focus on the potential role of TMAO in endothelial inflammatory injury. Finally, the utility of TMAO-targeted therapeutic strategies for the treatment of AS is also analyzed.http://dx.doi.org/10.1155/2020/4634172 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yarong Liu Min Dai |
spellingShingle |
Yarong Liu Min Dai Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis Mediators of Inflammation |
author_facet |
Yarong Liu Min Dai |
author_sort |
Yarong Liu |
title |
Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis |
title_short |
Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis |
title_full |
Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis |
title_fullStr |
Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis |
title_full_unstemmed |
Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis |
title_sort |
trimethylamine n-oxide generated by the gut microbiota is associated with vascular inflammation: new insights into atherosclerosis |
publisher |
Hindawi Limited |
series |
Mediators of Inflammation |
issn |
0962-9351 1466-1861 |
publishDate |
2020-01-01 |
description |
Trimethylamine N-oxide (TMAO) is a biologically active molecule generated by the gut microbiota. Accumulating evidences have indicated a close association between high plasma TMAO levels and the risk of developing atherosclerosis (AS). AS is considered a chronic inflammatory disease initiated by vascular endothelial inflammatory injury. Both observational and experimental studies suggest that TMAO can cause endothelial inflammatory injury. However, a clear mechanistic link between TMAO and vascular inflammation of AS is not yet summarized. In this review, we discuss the association between TMAO and AS and focus on the potential role of TMAO in endothelial inflammatory injury. Finally, the utility of TMAO-targeted therapeutic strategies for the treatment of AS is also analyzed. |
url |
http://dx.doi.org/10.1155/2020/4634172 |
work_keys_str_mv |
AT yarongliu trimethylaminenoxidegeneratedbythegutmicrobiotaisassociatedwithvascularinflammationnewinsightsintoatherosclerosis AT mindai trimethylaminenoxidegeneratedbythegutmicrobiotaisassociatedwithvascularinflammationnewinsightsintoatherosclerosis |
_version_ |
1715358105086197760 |